Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Orexigen Therapeutics Inc (NASDAQ:OREX)

0.4169
Delayed Data
As of May 27
 +0.0069 / +1.68%
Today’s Change
0.35
Today|||52-Week Range
5.19
-75.76%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2015
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
Revenue and IncomeNet Revenues5.2M10.0M4.9M5.0M
 
 
 
 
 
Depreciation And Amortization52.0K54.0K66.0K78.0K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses25.9M20.9M17.8M28.3M
 
 
 
 
 
Research And Development15.1M8.8M5.6M11.8M
 
 
 
 
 
Total Operating Expenses25.9M20.9M17.8M28.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-20.7M-10.9M-12.9M-23.3M
 
 
 
 
 
Interest Expense On Debt1.8M1.9M1.9M1.9M
 
 
 
 
 
Other Expenses0.001.6M-1.7M2.8M
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-22.5M-11.1M-16.4M-22.3M
 
 
 
 
 
Income Taxes0.000.00-1.4M0.00
 
 
Net Income-22.5M-11.1M-17.8M-22.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS125.2M129.7M145.5M145.6M
 
 
 
 
 
Shares To Calculate EPS Diluted125.2M129.7M145.5M145.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.18-$0.09-$0.12-$0.15
 
 
 
 
 
EPS Diluted-$0.18-$0.09-$0.12-$0.15